Catherine Owen Adams serves as the Chief Executive Officer of Acadia Pharmaceuticals Inc., a NASDAQ-listed biotech company known for its two marketed products, over $1Bn in sales, and a pipeline focused on neurological and rare diseases. She assumed this role in 2024, bringing over 25 years of leadership experience within the pharmaceutical industry.
Her extensive career includes significant tenures at Bristol Myers Squibb, Johnson & Johnson, and AstraZeneca.